I am an IT Manager with experience in the following industries: Pharma, Government, Banking and TelCo. I have a strong propensity for technological innovation, and its use inside companies to proactively contribute to processes improvement along the entire value chain.

Something about me from the professional point of view.
- Passionate of technology - My first pc, TI99/4A, when I was 11
- A strong advocate of adopting detailed work plans as enabler to get any goal
- Equipped with practical sense
- Being able to listen and valorize my team contribution

My history.
I graduated in Mathematics at the University of Rome, Tor Vergata. After a collaboration with the university, I worked in Mediamed Interactive, developing digital training solutions for the sales force of Pharma industry. After this experience, I joined Accenture and Avanade where I was involved in big projects/programs for the largest national and multinational companies.

After the consulting experience, I moved to Biomedica Foscama Group where, for more than five years, I was the head of IT department. Then, I moved to Alfasigma to lead IT activities for the Manufacturing area. Currently I’m in charge of IT development for the Manufacturing area covering all Alfasigma plants, with a particular focus on Industry 4.0. I’m also the CTO for the Pescara plant.

With over 15 years of specialized experience in pharmaceutical and biotech engineering, Oliver Kaerst is a distinguished leader in the field. As Head of Global Healthcare Operations (GHO) Engineering, he oversees engineering and capital expenditure initiatives across 20 manufacturing sites worldwide, driving excellence in pharmaceutical manufacturing and packaging.

Oliver has a proven track record in leading global pharma engineering and packaging reliability programs, including the successful integration of IoT and Industry 4.0 technologies. He also contributes as a key advisor on the Pharma Maintenance USA advisory board, where he offers expert guidance and highlights emerging trends in global maintenance practices.

His extensive background in strategic project management, regulatory compliance, and operational improvement underscores his leadership and deep expertise in optimizing complex global operations.

Driven by purpose, trust, and respect, I am a highly skilled professional with expertise across Strategic Asset Management, Reliability and Maintenance Management, and end-to-end Supply Chain processes. My capabilities span Production Packaging flow, Project Management, and LEAN TMP Manufacturing, including the AM/PM, T&D, and FI pillars.

With a strong foundation in KPIs/KAIs, PMS Visual Management, Change Management, and Procurement (MRO), I bring a results-oriented approach to improving operational efficiency. My deep knowledge in OPEX-CAPEX finance further enhances my ability to align technical solutions with strategic goals.

I hold a Master’s Degree in Production Mechanical Engineering from the University of Novi Sad, Serbia - Faculty of Technical Sciences. My master’s thesis focused on improving the efficiency of production systems using LEAN tools, reflecting my commitment to optimizing processes and driving innovation.

Pharmaceutical engineering leader with over 25 years of manufacturing experience spanning engineering disciplines including maintenance/reliability, capital projects, plant/process engineering, facilities management, and qualification/validation. Adept at engaging stakeholders, charting strategy, building networks, and developing effective organizations. Models behaviors that promote safety, compliance, continuous improvement, and accountability. Experienced with direct in-plant leadership as well as indirect influence across international organizations.

Severino is a seasoned engineering leader in the pharmaceutical industry, with deep expertise in reliability-centered maintenance, equipment performance optimization, and digital transformation. He specializes in leveraging asset management, process engineering, and data analytics to drive operational excellence across global manufacturing networks. Passionate about innovation, Severino leads the adoption of AI-powered tools to enhance maintenance strategy, reduce downtime, and ensure compliance in highly regulated environments. His work consistently bridges technical depth with strategic impact, empowering teams to deliver smarter, more resilient operations.

Our mission is to improve people's health and quality of life by offering caregivers and healthcare professionals therapeutic solutions according to the highest standards of quality and safety, in the name of innovation. Alfasigma is one of the leading Italian pharmaceutical companies, operating in over 100 countries worldwide with approximately 4,000 employees dedicated to research, development, production, and distribution. With more than 70 years of history, the Company has a longstanding track record in developing innovative therapeutic indications to meet the new needs of patients while renewing and consolidating its existing products. Alfasigma has a strong focus in gastroenterology and worldwide has products also in vascular, metabolic areas and in nutraceuticals and medical foods. As part of its strategy to expand its specialty care portfolio, Alfasigma strengthened its international presence with targeted acquisitions in US and Europe in 2023. Alfasigma’s historical headquarters are located in Bologna, with another office in Milan. It has production sites in Italy, in Pomezia (RM), Alanno (PE), Sermoneta (LT) and Trezzano Rosa (MI), and abroad in Tortosa, Spain and in Shreveport (Louisiana) in the United States. Its R&D laboratories are in Pomezia and in the Parco Scientifico Tecnologico Kilometro Rosso in Bergamo.

Our passion for science and technology is what drives our around 63,000 employees across 65 countries to find solutions to some of today’s toughest challenges and create more sustainable ways to live. We are here for people at every step, helping create, improve and prolong life. We deliver personalized treatments for serious diseases and enable people to achieve their dream of becoming parents. We empower the scientific community. Our tools, services, and digital platform make research simpler, more exact, and help to deliver breakthroughs more quickly. We provide progressive treatment solutions that help improve access to health thanks to the accuracy of our tests and the reliability of our medicine. As a company, we are at the forefront of digital living. Our science sits inside technologies that change the way we access, store, process, and display information. Our innovative technology drives human progress and opens new possibilities to transform life on Earth as we know it. Thanks to the constant curiosity of our employees, we are making discoveries that can change the landscape of entire industries. For more than 350 years, we’ve been pushing the boundaries of what’s possible, and we’ll continue to do so in the years to come.

We are a global healthcare company, founded in 1923 and headquartered just outside Copenhagen, Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure the diseases we treat. We employ more than 77,000 people in 80 offices around the world, and market our products in 170 countries. Our history spans a century and it all began with two small Danish companies, Nordisk Insulinlaboratorium and Novo Terapeutisk Laboratorium. After hearing of the discovery of insulin in 1921, Danish Nobel laureate August Krogh and his wife Marie, a doctor living with diabetes, were intrigued. At Marie’s urging, August travelled to Canada to seek permission from the researchers to produce this life-saving medicine in Denmark. Upon August’s return, Marie also convinced the scientist Hans Christian Hagedorn to join her husband and August Kongsted from Løvens Kemiske Fabrik. In March 1923, the first patients were treated with their insulin, setting in motion a century of innovation within protein-based treatments for people living with serious chronic diseases. For more information visit novonordisk.com.

We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines, as well as many of the world's best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us.